The medical community is excited with anticipation surrounding retatrutide, a novel dual GIP and GLP-1 target that’s exhibiting significant efficacy in clinical trials for managing obesity. Unlike some current weight loss treatments, retatrutide appears to deliver a significant substantial loss in body mass and benefit metabolic health, particul… Read More